CRY - CryoLife, Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
275,146
276,222
262,841
189,702
180,380
Cost of revenue
92,235
93,209
89,857
61,060
61,481
Gross profit
182,911
183,013
172,984
128,642
118,899
Operating expenses
Research development
23,768
22,960
23,098
19,461
13,446
Selling general and administrative
145,493
143,011
140,574
101,211
91,548
Total operating expenses
169,261
165,971
163,672
120,672
104,994
Operating income or loss
13,650
17,042
9,312
7,970
13,905
Interest expense
14,380
14,886
15,788
4,881
3,043
Total other income/expenses net
-4,835
-1,250
-141
260
7,478
Income before tax
-4,841
1,644
-6,391
3,561
18,412
Income tax expense
-193
-76
-3,551
-143
7,634
Income from continuing operations
-4,648
1,720
-2,840
3,704
10,778
Net income
-4,648
1,720
-2,840
3,704
10,778
Net income available to common shareholders
-4,619
1,708
-2,813
3,641
10,570
Basic EPS
-
0.05
-0.10
0.11
0.33
Diluted EPS
-
0.05
-0.10
0.11
0.32
Basic average shares
-
37,118
36,412
33,008
31,855
Diluted average shares
-
37,860
36,412
34,163
32,822
EBITDA
-
34,847
27,492
18,187
29,839